propionyl-l-carnitine nitric oxide NO Inducers* Carnitine Erectile Dysfunction Ncbi: An
Description
Acta Neurol Scand 91 : 247250
ODC1 is a critical determinant of MYCN oncogenesis and a therapeutic target in neuroblastoma
A large cohort study involving over 1.4 million transfusion recipients found no increased PD risk in those who received blood from donors later diagnosed with neurodegenerative diseases, supporting transfusion safety [291]
Pannala VR, Bazil JN, Camara AKS, Dash RK
